UCB, INC.

Lobbying for UCB, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $750,000.00 expenses · posted Jul 21, 2025

Bills named in this filing 2

HR 946
ORPHAN Cures Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 4

Medicare/Medicaid

Medicare Home Infusion

Pharmacy

HR 946 - ORPHAN Cures Act S 1862 - ORPHAN Cures Act Drug Pricing

Taxation/Internal Revenue Code

HR 1

Tariff (miscellaneous tariff bills)

Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.